Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT03638206	TitleAutologous CAR-T/TCR-T Cell Immunotherapy for Malignancies	Fase Fase 1/Fase 2	Date Added 2018-08-20	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas CAR-T cell immunotherapy	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03772561	TitlePhase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies	Fase Fase 1	Date Added 2018-12-11	Ubicación Singapur	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas AZD5363+Olaparib+Durvalumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT02343991	TitleBlood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound	Fase No aplicable	Date Added 2015-01-22	Ubicación Canadá	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas Transcranial ExABlate	Etiquetas MSS/ MMRp
NCT ID NCT04991948	TitleStudy of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer	Fase Fase 1	Date Added 2021-08-05	Ubicación Florida, United States Bélgica	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas CYAD-101, FOLFOX, Pembrolizumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05299840	TitleImpact of Using the Oncogramme(R) Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer	Fase No aplicable	Date Added 2022-03-29	Ubicación Francia	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03865082	TitleStudy of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)	Fase Fase 2	Date Added 2019-03-06	Ubicación Arizona, United States California, United States Texas, United States	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas Ipilimumab, Nivolumab, Tilsotolimod, Opdivo, Yervoy	Etiquetas MSS/ MMRp
NCT ID NCT03366155	TitleHepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver	Fase Fase 2	Date Added 2017-12-08	Ubicación Maryland, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas 5FU, cetuximab, FUDR-Dex, Irinotecan, Medtronic SynchroMed II Pump with Codman 3000 Constant Flow Pump Catheter, OneRNA, oxaliplatin, panitumumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03297606	TitleCanadian Profiling and Targeted Agent Utilization Trial (CAPTUR)	Fase Fase 2	Date Added 2017-09-29	Ubicación Canadá	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas Axitinib, Bosutinib, Crizotinib, Dasatinib, Erlotinib, Nivolumab plus Ipilimumab, Olaparib, palbociclib, Sunitinib, Temsirolimus, Trastuzumab plus Pertuzumab, Vemurafenib plus Cobimetinib, Vismodegib	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03488953	TitleTrasplante hepático de donante vivo con hepatectomía en dos fases para pacientes con metástasis hepáticas colorrectales aisladas e irresecables	Fase No aplicable	Date Added 2018-04-05	Ubicación Alemania	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04660812	TitleAn Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.	Fase Phase 1, Phase 2	Date Added 2020-12-09	Ubicación Alabama, United States Arizona, United States California, United States Connecticut, United States District of Columbia, United States Georgia, United States Louisiana, United States Maryland, United States Missouri, United States Nevada, United States New York, United States Pennsylvania, United States South Carolina, United States Tennessee, United States Texas, United States Wisconsin, United States Francia Italia Corea, República de España Reino Unido	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas AB680, Bevacizumab, Etrumadenant, mFOLFOX-6 regimen, Regorafenib, Zimberelimab	Etiquetas MSS/ MMRp

Showing 241 to 250 of 299 entries